Related Experiment Video
Updated: Jan 5, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
Looking to the future of depression: instant diagnosis and medication-free treatment
1Co-founder & Clinical Psychologist, Flow.
Abstract:
Daniel Mansson is a clinical psychologist, cofounder and CEO of Flow. As a clinical psychologist at Sarpsborg DPS, a psychiatric clinic in Norway, Daniel performed extensive investigations and treatments for patients with conditions including depression and attention deficit hyperactivity disorder. In 2012, Daniel met Erik Rehn, where they both worked in the research department of computational biology at KTH Royal Institute of Technology, Stockholm. In January 2016, with combined backgrounds in clinical psychology, computer networks, computational neuroscience and electrical engineering, they launched Flow. The mission was simple: to find new ways to treat mental health issues with the help of science and technology. Based in Malmo, Sweden, Daniel is the driving force behind Flow and spearheads the research, innovation and business development.
Related Concept Videos
Drug Therapy
Antianxiety Medications
Electroconvulsive Therapy
Depression: Overview
Long-term Depression
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...

